Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Drake

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Immunohorizons|September 19, 2025
Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiologyMolly Griggs, Victoria Daylor, Taylor Petrucci, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Schizophrenia Bulletin|October 15, 2020
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE StudyPaola Dazzan, Andrew J Lawrence, Antje A T S Reinders, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
Immunohorizons|September 19, 2025
Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiologyMolly Griggs, Victoria Daylor, Taylor Petrucci, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Schizophrenia Bulletin|October 15, 2020
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE StudyPaola Dazzan, Andrew J Lawrence, Antje A T S Reinders, et al.
Pageof 10